More people with HIV/AIDS are getting inexpensive anti-retroviral drugs and their life-expectancy has increased, but universal access is still far off, and the disease is still spreading, if more slowly than before.
Plus de personnes malades du VIH/SIDA ont accès aux médicaments antirétroviraux bon marché, mais elles ne sont pas encore en majorité et le virus continue, plus lentement, à gagner du terrain.